Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Frequency of Rs2231142 in ABCG2 among Asian Subgroups: Implications for Personalized Rosuvastatin Dosing

Pharmacogenomics(2023)10.2217/pgs-2022-0155Source: DataRank Database

The Frequency of Rs2231142 in ABCG2 among Asian Subgroups: Implications for Personalized Rosuvastatin Dosing is a research paper published in Pharmacogenomics (2023). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 2.30)OA: greenTopics (48)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Youssef M. Roman ORCID,Khalifa Alrajeh ORCID

Live enrichment

PubMed:36651271 PMC:PMC9979151 OpenAlex:https://openalex.org/W4317209295

National Institute on Minority Health and Health Disparities

Grant: G12MD007601, U54MD007584

National Institute General Medical Sciences

Grant: P20GM103466

NIMHD NIH HHS

Grant: U54 MD007584

NIMHD NIH HHS

Grant: G12 MD007601

National Institutes of Health

Grant: 5U54MD007584-07

RCMI Multidisciplinary And Translational Research Infrastructure EXpansion (RAMAT

National Institutes of Health

Grant: 8P20GM103466-11

INBRE II: Hawaii Statewide Research & Education Partnership (HSREP)

FWCI

2.30

Citation Percentile

0.9%

Influential Citations

Citation Trend

2023

2024

2025

2026

green

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC9979151/pdf/pgs-24-15.pdf

publisherhttps://www.tandfonline.com/doi/pdf/10.2217/pgs-2022-0155

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9979151

journalhttps://doi.org/10.2217/pgs-2022-0155

Fields of Study

Drug Transport and Resistance MechanismsLipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismMedicine03 medical and health sciences0302 clinical medicineHumansRosuvastatin CalciumATP-Binding Cassette TransportersPolymorphism, Single NucleotideHydroxymethylglutaryl-CoA Reductase InhibitorsGenotypeATP Binding Cassette Transporter, Subfamily G, Member 2Neoplasm Proteins

MeSH Terms

Rosuvastatin CalciumATP Binding Cassette Transporter, Subfamily G, Member 2GenotypeHumansNeoplasm ProteinsATP-Binding Cassette TransportersHydroxymethylglutaryl-CoA Reductase InhibitorsPolymorphism, Single Nucleotide

Keywords

RosuvastatinDosingMedicineInternal medicinePharmacologyPopulationGenotypeStatinBiologyEnvironmental healthGeneticsAdverse drug reactionDyslipidemiaABCG2FilipinosstatinsDrug TransportersCardiovascular PharmacogenomicsAsian AncestryHumansATP Binding Cassette Transporter, Subfamily G, Member 2ATP-Binding Cassette TransportersRosuvastatin CalciumHydroxymethylglutaryl-CoA Reductase InhibitorsPolymorphism, Single NucleotideNeoplasm Proteins

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

The Frequency of Rs2231142 in ABCG2 among Asian Subgroups: Implications for Personalized Rosuvastatin Dosing

FAIR Checklist

Authors (2)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)